Introduction to a How I Treat series on emergent CAR T-cell toxicities

Free article

Editorial

Helen E Heslop. Blood. 2023.

Free article

. 2023 May 18;141(20):2405-2407.

doi: 10.1182/blood.2023020228.

No abstract available

Comment on

How I treat cytopenias after CAR T-cell therapy.
Jain T, Olson TS, Locke FL. Jain T, et al. Blood. 2023 May 18;141(20):2460-2469. doi: 10.1182/blood.2022017415. Blood. 2023. PMID: 36800563 Free PMC article.
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy.
Gutierrez C, Neilan TG, Grover NS. Gutierrez C, et al. Blood. 2023 May 18;141(20):2452-2459. doi: 10.1182/blood.2022017579. Blood. 2023. PMID: 36827628 Free PMC article.
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity.
Santomasso BD, Gust J, Perna F. Santomasso BD, et al. Blood. 2023 May 18;141(20):2443-2451. doi: 10.1182/blood.2022017604. Blood. 2023. PMID: 36877916 Free PMC article.
How I treat refractory CRS and ICANS after CAR T-cell therapy.
Jain MD, Smith M, Shah NN. Jain MD, et al. Blood. 2023 May 18;141(20):2430-2442. doi: 10.1182/blood.2022017414. Blood. 2023. PMID: 36989488 Free PMC article.